Form D · Biotechnology

Access Vascular, Inc.

Bedford, MA · CIK 0001714846

Offering snapshot reported Oct 30, 2023 · SEC filing

Reported sold
$20.6M
Offering amount: $31.6M
Investors reported
19
Form D · investor count
Minimum accepted
$7.98K
Reported outside-investor minimum
First sale
Oct 13, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 30, 2023Initial$20,646,440No comparison19SEC filing
Oct 19, 2022Initial$0No comparison2SEC filing
Mar 9, 2021Initial$19,895,191No comparison14SEC filing
Sep 9, 2019Initial$5,552,706No comparison15SEC filing
May 16, 2018Initial$1,922,000No comparison7SEC filing
Aug 16, 2017Initial$3,774,000No comparison25SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-495942

Source: Form D, filed Oct 30, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Amine Bentaleb Director
James Biggins Executive
Michael R Jaff Director
Alexandra Mac Lean Director
Luc Marengere Director
Joseph Pellegrino Director
Jj Pelligrino Director
Brent Ratz Director
Marc Riviere Director
Brent Sabin Director
Paul Sabin Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
175 Middlesex Turnpike, Suite 1 A
Bedford, MA, 01730